E
Ultragenyx Pharmaceutical Inc. RARE
$39.34 $0.090.23%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income 6.17% 12.01% 18.82% 14.70% 14.25%
Total Depreciation and Amortization 36.67% 52.48% 63.55% 52.91% 42.73%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -12.73% -26.55% -53.66% -56.23% -51.34%
Change in Net Operating Assets 192.17% 168.19% -283.91% -197.60% -125.07%
Cash from Operations 12.77% 13.02% -2.34% -21.17% -24.80%
Capital Expenditure 83.08% 87.88% 88.57% 79.40% 61.88%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -104.84% -226.87% 177.33% 323.23% 311.20%
Cash from Investing -110.58% -320.00% 191.48% 205.70% 157.60%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 1.05% 1,108.28% 1,992.38% 4,185.38% 3,489.85%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 25,100.00% 4,861.90% -100.00% -99.87% -100.01%
Cash from Financing 2.86% 1,123.05% 40.81% -22.06% -22.56%
Foreign Exchange rate Adjustments -646.54% 47.82% -371.68% 43.39% 142.98%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -143.08% 125.69% 795.02% 147.69% 147.56%
Weiss Ratings